Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.

Vinik A, Rosenstock J, Sharma U, Feins K, Hsu C, Merante D; DS5565-A-U201 US Phase II Study Investigators.

Diabetes Care. 2014 Dec;37(12):3253-61. doi: 10.2337/dc14-1044. Epub 2014 Sep 17.

PMID:
25231896
[PubMed - in process]
2.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.

PMID:
24881993
[PubMed - indexed for MEDLINE]
3.

Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare).

Bode BW, Chaykin LB, Sussman AM, Warren ML, Niemeyer M, Rabøl R, Rodbard HW.

Endocr Pract. 2014 Aug;20(8):785-91. doi: 10.4158/EP13411.OR.

PMID:
24518180
[PubMed - in process]
4.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17.

PMID:
23863814
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1.

PMID:
23818528
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.

Aschner P, Chan J, Owens DR, Picard S, Wang E, Dain MP, Pilorget V, Echtay A, Fonseca V; EASIE investigators.

Lancet. 2012 Jun 16;379(9833):2262-9. doi: 10.1016/S0140-6736(12)60439-5. Epub 2012 Jun 9.

PMID:
22683131
[PubMed - indexed for MEDLINE]
7.

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J; Liraglutide-Detemir Study Group.

Diabetes Care. 2012 Jul;35(7):1446-54. doi: 10.2337/dc11-1928. Epub 2012 May 14.

PMID:
22584132
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.

Willerson JT, Cable G, Yeh ET; PROCLAIM Investigators.

Tex Heart Inst J. 2009;36(6):530-9.

PMID:
20069077
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.

Raskin P, Gylvin T, Weng W, Chaykin L.

Diabetes Metab Res Rev. 2009 Sep;25(6):542-8. doi: 10.1002/dmrr.989.

PMID:
19565569
[PubMed - indexed for MEDLINE]
10.

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

Diabetes Obes Metab. 2009 Oct;11(10):947-52. doi: 10.1111/j.1463-1326.2009.01069.x. Epub 2009 Jun 16.

PMID:
19531054
[PubMed - indexed for MEDLINE]
11.

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.

Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

Diabetes Obes Metab. 2009 Sep;11(9):865-73. doi: 10.1111/j.1463-1326.2009.01062.x. Epub 2009 May 19.

PMID:
19476470
[PubMed - indexed for MEDLINE]
12.

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.

PMID:
17941873
[PubMed - indexed for MEDLINE]
13.

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes.

Hanefeld M, Herman GA, Wu M, Mickel C, Sanchez M, Stein PP; Sitagliptin Study 014 Investigators.

Curr Med Res Opin. 2007 Jun;23(6):1329-39. Epub 2007 Apr 30.

PMID:
17559733
[PubMed - indexed for MEDLINE]
14.

Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.

Defelice EA, Chaykin LB, Cohen A.

Curr Ther Res Clin Exp. 1973 Jul;15(7):358-66. No abstract available.

PMID:
4198296
[PubMed - indexed for MEDLINE]
15.

Spondylitis of hypoparathyroidism.

Jimenea CV, Frame B, Chaykin LB, Sigler JW.

Clin Orthop Relat Res. 1971 Jan;74:84-9. No abstract available.

PMID:
5540408
[PubMed - indexed for MEDLINE]
16.

Spondylitis: a clue to hypoparathyroidism.

Chaykin LB, Frame B, Sigler JW.

Ann Intern Med. 1969 May;70(5):995-1000. No abstract available.

PMID:
5769633
[PubMed - indexed for MEDLINE]
17.

Maternal hyperparathyroidism and pregnancy.

Rubin A, Chaykin L, Ludwig GD.

JAMA. 1968 Sep 30;206(1):128-30. No abstract available.

PMID:
5695435
[PubMed - indexed for MEDLINE]
18.

Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH.

Buckalew VM Jr, McCurdy DK, Ludwig GD, Chaykin LB, Elkinton JR.

Am J Med. 1968 Jul;45(1):32-42. No abstract available.

PMID:
5658867
[PubMed - indexed for MEDLINE]
19.

Cerebral gigantism with intermittent fractional hypopituitarism and normal sella turcica.

Ludwig GD, Chaykin LB, Escueta AV.

Ann Intern Med. 1967 Jul;67(1):123-31. No abstract available.

PMID:
6028644
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk